PharmacyCodes



Metisergide [DCIT] en es it fr

Metisergide [DCIT] Brand names, Metisergide [DCIT] Analogs

Metisergide [DCIT] Brand Names Mixture

  • No information avaliable

Metisergide [DCIT] Chemical_Formula

C21H27N3O2

Metisergide [DCIT] RX_link

http://www.rxlist.com/cgi/generic3/sansert.htm

Metisergide [DCIT] fda sheet

Metisergide [DCIT] msds (material safety sheet)

Metisergide [DCIT] Synthesis Reference

No information avaliable

Metisergide [DCIT] Molecular Weight

353.458 g/mol

Metisergide [DCIT] Melting Point

195 oC

Metisergide [DCIT] H2O Solubility

No information avaliable

Metisergide [DCIT] State

Solid

Metisergide [DCIT] LogP

1.55

Metisergide [DCIT] Dosage Forms

Tablet

Metisergide [DCIT] Indication

For the treatment of vascular headache

Metisergide [DCIT] Pharmacology

Methysergide has been shown, in vitro and in vivo, to inhibit or block the effects of serotonin, a substance which may be involved in the mechanism of vascular headaches. Serotonin has been variously described as a central neurohumoral agent or chemical mediator, as a "headache substance" acting directly or indirectly to lower pain threshold, as an intrinsic "motor hormone" of the gastrointestinal tract, and as a "hormone" involved in connective tissue reparative processes.

Metisergide [DCIT] Absorption

Rapid

Metisergide [DCIT] side effects and Toxicity

No information avaliable

Metisergide [DCIT] Patient Information

No information avaliable

Metisergide [DCIT] Organisms Affected

Humans and other mammals